DC Medical
Israel
Company Overview
Commercialization of the preterm birth diagnostic device which shows superior performance on accuracy, portability, test result drawing speed, affordability, diagnosable group compared to existing methods
Sectors
- Bio Medical
Project Summary
- Portable preterm birth diagnostic device using EIS technology
Business Model
- Revenue model Sales of the product/ Licensing out and royalty revenue
- Key Customer Health Authorities, University hospitals
Major Performance
-
Sales
- 2020-$10,000
-
Investment
- $9,651,623
- VCs,
- private investors
-
Employees
- 2021-9
-
Patent
- S. Korea(Granted 1)
- Global(Granted 1/ Applied 4)
- Trademarks(Granted 4/ Applied 6)
Overseas Expansion
Stage
Preparing for overseas expansion
Status
Preparing for multi-national clinical trials in Korea, Dubai, and Great Britain
Performance
- 1. Selected for the Dubai government program, Future Accelerator
- 2. Awarded on Johnson and Johnson QuickFire Challenge
Short-term goals in three years
- Finish multi-national clinical trials, approvals and launch our commercial product
Products / Services
1
2
- Target Country
- Israel
- Date of Establishment
- Aug 06, 2018
-
- info@dcmedical.co.kr info@dcmedical.co.kr
-
- Website
- http://dcmedical.co.kr/ http://dcmedical.co.kr/
-
- Location
- Seocho-gu, Seoul, Korea
-
- CEO
- Dabriel Cho
-
- Founder’s Background
-
- DC Medical, CEO(2018~Present)
- InterMedi Group, Founder & Board of Director(2017~Present)
- University of the Arts London, BA Arts, Design and Environment(2007~2010)